STK11 and neoplasm: Tumors with loss of or mutated LKB1 had significantly lower infiltration of immune-competent cells (CD4, CD8-effector, and NK cells), tumor-associated macrophages (TAMs), and T regulatory cells than tumors harboring WT LKB1 (Supplementary Fig. 3).